Pathogenic mutation in a patient with Oguchi disease
10.3760/cma.j.cn511434-20190628-00206
- VernacularTitle:小口病致病基因诊断
- Author:
Luqi XIA
1
;
Xuebi CAI
;
Yihan ZHENG
;
Xinran WEN
;
Fangyue ZHOU
;
Nobuyuki NAO-I
;
Zibing JIN
Author Information
1. 温州医科大学附属眼视光医院遗传眼病专科 眼视光学与视觉科学国家重点实验室视网膜再生医疗研究组 神经遗传与再生医学国际联合研究中心 325027
- From:
Chinese Journal of Ocular Fundus Diseases
2020;36(3):192-195
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To identify the pathogenic mutation in a patient with Oguchi disease.Methods:A Japanese patient with Oguchi disease was enrolled in this study, and underwent a comprehensive medical history assessment and multiple ophthalmic examinations, including BCVA, OCT, color fundus photography and full field electroretinogram. Genomic deoxyribonucleic acid (DNA) was extracted from peripheral blood samples for whole exome sequencing. The gene mutation was detected, and the analysis software was used to determine the conservation of the mutation and the possible structural changes.Results:The patient, 71 years old, with consanguineous parents, complained of night blindness since early childhood. BCVA in both eyes was 0.7 and the golden-yellowish reflex appeared in the grey retina. The scotopic 0.01 ERGs showed a extinguished reaction in both eyes. The scotopic 3.0 ERGs showed a "negative" configuration with a significantly reduced a wave and a nearly absent b wave. A homozygous deletion mutation in the SAG gene (c.924delA, p.N309Tfs*12) in this patient was founded by DNA sequencing, which was predicted to generate prematurely truncated SAG protein and result in severe structural change. Homology analysis of the protein sequence indicated that the mutation resulted in an altered amino acid which was evolutionarily highly conserved among different species, strongly suggesting the potential pathogenicity of this homozygous mutation.Conclusion:The mutation c.924delA(309Tfs*12) in SAG cause Oguchi disease in this patient.